Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells

Carcinogenesis

Volumn 34, Issue 11, 2013, Pages 2587-2592

  Yang, Li ^a   Zahid, Muhammad ^b   Liao, Yong ^a   Rogan, Eleanor G ^b   Cavalieri, Ercole L ^b   Davidson, Nancy E ^a,c   Yager, James D ^d   Visvanathan, Kala ^d   Groopman, John D ^d   Kensler, Thomas W ^a,c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYESTRADIOL; ADENINE; ESTRADIOL; ESTROGEN; ESTRONE; GLUTATHIONE TRANSFERASE; GUANINE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2;

ARTICLE; BREAST CELL; CARCINOGENESIS; CHEMICAL STRUCTURE; CONJUGATION; DNA ADDUCT; DNA DAMAGE; ENZYME ACTIVITY; EPITHELIUM CELL; ESTROGEN METABOLISM; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTICARCINOGENIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BREAST; CELL PROLIFERATION; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA ADDUCTS; ESTROGENS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOTHIOCYANATES; NF-E2-RELATED FACTOR 2; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY;

EID: 84887000882     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt246     Document Type: Article

References (43)

1. Yager,J.D. et al. (2006) Estrogen carcinogenesis in breast cancer. N. Engl. J. Med., 354, 270-282.
2. Yager,J.D. (2000) Endogenous estrogens as carcinogens through metabolic activation. J. Natl Cancer Inst. Monogr., 27, 67-73.
3. Lu,F. et al. (2008) Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prev. Res., 1, 135-145.
4. Zahid,M. et al. (2008) Prevention of estrogen-DNA adduct formation in MCF-10F cells by resveratrol. Free Radic. Biol. Med., 45, 136-145.
5. Feigelson,H.S. et al. (1996) Estrogens and breast cancer. Carcinogenesis, 17, 2279-2284.
6. Hayes,C.L. et al. (1996) 17 beta-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl Acad. Sci. USA, 93, 9776-9781.
7. Zahid,M. et al. (2006) The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity. Chem. Res. Toxicol., 19, 164-172.
8. Cavalieri,E.L. et al. (2011) Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer. J. Steroid Biochem. Mol. Biol., 125, 169-180.
9. Cavalieri,E. et al. (2006) Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim. Biophys. Acta, 1766, 63-78.
10. Mailander,P.C. et al. (2006) Induction of A.T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats. J. Steroid Biochem. Mol. Biol., 101, 204-215.
11. Singh,S. et al. (2005) Relative imbalances in the expression of estrogenmetabolizing enzymes in the breast tissue of women with breast carcinoma. Oncol. Rep., 14, 1091-1096.
12. Gaikwad,N.W. et al. (2008) The molecular etiology of breast cancer: evidence from biomarkers of risk. Int. J. Cancer, 122, 1949-1957.
13. Gaikwad,N.W. et al. (2009) Urine biomarkers of risk in the molecular etiology of breast cancer. Breast Cancer, 3, 1-8.
14. Pruthi,S. et al. (2012) Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk. J. Steroid Biochem. Mol. Biol., 132, 73-79.
15. Fahey,J.W. et al. (1997) Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl Acad. Sci. USA, 94, 10367-10372.
16. Zhang,Y. et al. (1992) A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl Acad. Sci. USA, 89, 2399-2403.
17. Cornblatt,B.S. et al. (2007) Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis, 28, 1485-1490.
18. Kensler,T.W. et al. (2010) Nrf2: friend or foe for chemoprevention? Carcinogenesis, 31, 90-99.
19. Mitsuishi,Y. et al. (2012) The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Front. Oncol., 2, 200. doi: 10.3389/ fonc.2012.00200.
20. Agyeman,S.A. et al. (2012). Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles. Breast Cancer Res. Treat., 132, 175-187.
21. Kensler,T.W. et al. (2013) Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top. Curr. Chem., 329, 163-177.
22. Cao,K. et al. (1998) Covalent binding of catechol estrogens to glutathione catalyzed by horseradish peroxidase. Chem. Res. Toxicol., 11, 917-924.
23. Stack,D.E. et al. (1996) Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem. Res. Toxicol., 9, 851-859.
24. Li,K.M. et al. (2004) Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis, 25, 289-297.
25. Debnath,J. et al. (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods, 30, 256-268.
26. Livak,K.J. et al. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.
27. Prochaska,H.J. et al. (1988) Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal. Biochem., 169, 328-336.
28. Li,J.J. et al. (1983) Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney. Cancer Res., 43, 5200-5204.
29. Liehr,J.G. et al. (1986) Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem., 24, 353-356.
30. Li,J.J. et al. (1987) Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed. Proc., 46, 1858-1863.
31. Newbold,R.R. et al. (2000) Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res., 60, 235-237.
32. Chakravarti,D. et al. (2001) Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene, 20, 7945-7953.
33. Zhao,Z. et al. (2006) Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB2 rat embryonic cells, and the mutational spectrum of 4-hydroxyestradiol. Chem. Res. Toxicol., 19, 475-479.
34. Bocchinfuso,W.P. et al. (1999) A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha. Cancer Res., 59, 1869-1876.
35. Santen,R. et al. (2009) Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann. N. Y. Acad. Sci., 1155, 132-140.
36. Huang,Y. et al. (2007) Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res., 67, 11147-11157.
37. Russo,J. et al. (2011) The role of the basal stem cell of the human breast in normal development and cancer. Adv. Exp. Med. Biol., 720, 121-134.
38. Lavigne,J.A. et al. (2012) The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells. Cancer Res., 61, 7488-7494.
39. Zahid,M. et al. (2007) Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation. Free Radic. Biol. Med., 43, 1534-1540.
40. Singh,S. et al. (2009) NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells. J. Steroid Biochem. Mol. Biol., 117, 56-66.
41. Yates,M.S. et al. (2009) Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis, 30, 1024-1031.
42. Malhotra,D. et al. (2010) Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res., 38, 5718-5734.
43. Zhang,Y. (2012) The molecular basis that unifies the metabolism, cellular uptake and chemopreventive activities of dietary isothiocyanates. Carcinogenesis, 33, 2-9.